Growth factor delivery

Lee, K., and Mooney, D. Controlled growth factor delivery for tissue engineering, in Dinh, S. and Liu, P (eds.), Advances in Controlled Drug Delivery Science, Technology, and Products. ACS Symposium Series 846, Washington, 2003, pp. 73-83. [Pg.137]

Vascular endothelial growth factor delivery to promote re-endothelialization... [Pg.356]

New cells, Genes Devices Growth Factors Delivery methods Cell Tracking Functional Analyses... [Pg.428]

Stupp, S.I., Dormers, J.J.J.M., Silva, G.A., and Behanna, H.A. Anthony, S.G. Self-Assembling Peptide Amphiphiles and Related Methods for Growth Factor Delivery, 2004-US40550 2005056039 (2005b). [Pg.10]

Sheridan, M.H. Shea, L.D. Peters, M.C. Mooney, D.J. 59. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J. Control. Release... [Pg.3582]

Hile DD, Amirpour ML, Akgerman A, Pishko MV. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO2. J Controlled Release 2000 66 177-185. [Pg.406]

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival- application to proliferation and cyto-toxicity assays. J hnmun Met 65 55-63 Nie T, Baldwin A, Yamaguchi N et al (2007) Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. J Control Release 122 287-296... [Pg.264]

Microencapsulated cells are potentially useful in other situations such as the treatment of Parkinson s disease (dopamine delivery), liver failure (hepatocytes), wound healing (growth factor delivery) and immune modulation/tumor therapy (interleukin 2 delivery). Other neurological applications under consideration include chronic pain relief (30) and Huntington s and Alzheimer s diseases (31). Such technology may also play a similar role in gene therapy to allow the use of genetically corrected/modified cells. [Pg.146]

Beaty, C.E. and W.M. Saltzman, Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures. Journal of Controlled Release, 1993, 24, 15-23. [Pg.277]

Lee J-Y, Nam S-FI et al (2002) Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 78 187-197... [Pg.41]

The approach developed by Sakiyama-Elbert et al., consisting in a cell-triggered growth factor delivery systan, may also be used for the release of other important therapeutic molecules. [Pg.971]

Q. Sun, R.R. Chen, Y. Shen, D.J. Mooney, S. Rajagopalan, P.M. Grossman, Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb, Pharm. [Pg.89]

R.R. Chen, D.J. Mooney, Polymeric growth factor delivery strategies for tissue engineering, Pharm. Res. 20 (2003) 1103-1112. [Pg.114]

T.R Richardson, M.C. Peters, A.B. Ennett, D.J. Mooney, Polymeric system for dual growth factor delivery, Nat. Biotechnol. 19 (2001) 1029-1034. [Pg.286]

X. Li, J. Wang, G. Su, Z. Zhou, J. Shi, L. Liu, M. Guan, Q. Zhang, Spatiotemporal control over growth factor delivery from collagen-based membrane, J. Biomed. Mater. Res. lOOA (2) (2012) 396-405. [Pg.295]

D.H. Choi, C.H. Park, l.H. Kim, H.J. Chun, K. Park, D.K. Han, Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system, J. Control. Release 147 (2) (2010) 193-201. [Pg.296]

Park, H., Temenoff, J. S., Tabata, Y., Caplan, A. I. Mikos, A. G. (2007) Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials, 28, 3217-27. [Pg.177]

Xu, H. H., Weir, M. D. Simon, C. G. (2008) Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater, 24, 1212-22. [Pg.180]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...